Haihua Yuan
Clinical trials sponsored by Haihua Yuan, explained in plain language.
-
New hope for advanced HER2 cancers? drug trial launches
Disease control Not yet recruitingThis early-phase study tests a drug called zanidatamab in 10 adults with advanced HER2-positive solid tumors (like endometrial, bladder, or pancreatic cancer) that have worsened after at least one prior treatment. Participants receive the drug by IV every two weeks. The main goal…
Phase: PHASE2 • Sponsor: Haihua Yuan • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New drug targets hard-to-treat cancers in early trial
Disease control Not yet recruitingThis study tests a drug called Trastuzumab Rezetecan in 15 adults with advanced solid tumors that have the HER2 protein. The goal is to see if the drug can shrink tumors. Participants get the drug by IV every 3 weeks. This is for people whose cancer has worsened after other treat…
Phase: PHASE2 • Sponsor: Haihua Yuan • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC